Cookies on the Economic Times website

Economic Times has updated its Privacy and Cookie policy. We use cookies to ensure that we give you the better experience on our website. If you continue without changing your settings,we'll assume that you are happy to receive all cookies on the Economic Times website. However, you can change your cookie setting at any time by clicking on our Cookie Settings at any time.You can also see our Privacy Policy

Pharmaceuticals

Centre looking to hike import duty on bulk drugs, in bid to boost local manufacturing

ThinkStock Photos

Synopsis

The department of pharmaceuticals (DoP) is mulling the proposal as it pushes to make India self-reliant on APIs. A committee of experts formed by the DoP has suggested increasing the customs duty on APIs by 10 percent.

By , ET Bureau
3 mins read, Last Updated:
NEW DELHI: The government is considering increasing the import duty on active pharmaceutical ingredients (APIs) to 20-25% from the current 10%, to help boost local manufacturing of the bulk drugs, people in the know told ET. The department of pharmaceuticals (DoP) is mulling the proposal as it pushes to make India self-reliant on APIs. A committee of experts formed by the DoP had suggested increasing the customs duty on APIs. "This will help the

To Read the Full Story, Become an ET Prime Member

Access the exclusive Economic Times stories, Editorial and Expert opinion

START FREE TRIAL

Why

  • Sharp Insight-rich, Indepth stories across 20+ sectors

  • Access the exclusive Economic Times stories, Editorial and Expert opinion

  • Clean experience with
    Minimal Ads
  • Comment & Engage with ET Prime community
  • Exclusive invites to Virtual Events with Industry Leaders
  • A trusted team of Journalists & Analysts who can best filter signal from noise
START FREE TRIAL